Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.

Questions of authorship have long haunted modern and contemporary art, but the arrival of computational systems has sharpened them into something more urgent.

ML is poised to become faster and more accessible by 2026. Simply having the support of GenAI already gives it an advantage over other AI-based solutions.

A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease.

A Hybrid Machine Learning Framework for Early Diabetes Prediction in Sierra Leone Using Feature Selection and Soft-Voting Ensemble ...